ESTIMATED
05/09/2024
05/09/2024
(AS OF MARCH 31)
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 1 | -$0.49 | -$0.49 | -$0.49 |
Q2 2024 | 3 | -$0.48 | -$0.44 | -$0.46 |
Q3 2024 | 1 | -$0.42 | -$0.42 | -$0.42 |
Q4 2024 | 1 | -$0.37 | -$0.37 | -$0.37 |
Q1 2025 | 1 | -$0.33 | -$0.33 | -$0.33 |
Q2 2025 | 1 | -$0.26 | -$0.26 | -$0.26 |
Q3 2025 | 1 | -$0.24 | -$0.24 | -$0.24 |
Q4 2025 | 1 | -$0.21 | -$0.21 | -$0.21 |
Q1 2026 | 0 | -$0.13 | -$0.13 | -$0.13 |
Q2 2026 | 0 | -$0.06 | -$0.06 | -$0.06 |
Q3 2026 | 0 | -$0.03 | -$0.03 | -$0.03 |
Q4 2026 | 0 | $0.03 | $0.03 | $0.03 |
TELA Bio, Inc. last posted its earnings results on Thursday, May 9th, 2024. The company reported $-0.23 earnings per share for the quarter, topping analysts' consensus estimates of $-0.48 by $0.25. The company had revenue of 16.60 M for the quarter and had revenue of 58.45 M for the year. TELA Bio, Inc. has generated $-2 earnings per share over the last year ($-2.04 diluted earnings per share) and currently has a price-to-earnings ratio of -2.65. TELA Bio, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 7th, 2024 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 05/10/2024 | Q1 2024 | -$0.23 | $16.32 M | $16.60 M | 03/22/2024 | Q4 2023 | -$0.53 | $16.46 M | $17.00 M | 11/13/2023 | Q3 2023 | -$0.45 | $15.05 M | 08/10/2023 | Q2 2023 | -$0.46 | $14.49 M | 05/11/2023 | Q1 2023 | -$0.51 | -$0.73 | -0.22 | $12.01 M | $11.91 M | 03/23/2023 | Q4 2022 | -$0.51 | $13.18 M | $11.62 M | 11/10/2022 | Q3 2022 | -$0.71 | $11.16 M | 08/11/2022 | Q2 2022 | -$0.92 | $10.41 M | 05/11/2022 | Q1 2022 | -$0.82 | $8.23 M | 03/23/2022 | Q4 2021 | -$0.59 | $7.97 M | $8.37 M | 11/12/2021 | Q3 2021 | -$0.57 | $7.55 M | $7.65 M | 08/12/2021 | Q2 2021 | -$0.57 | $6.31 M | $7.56 M | 05/14/2021 | Q1 2021 | -$0.56 | $5.88 M | 03/25/2021 | Q4 2020 | -$0.54 | $5.81 M | $5.67 M | 11/12/2020 | Q3 2020 | -$0.53 | $4.57 M | $5.31 M | 08/13/2020 | Q2 2020 | -$0.53 | $1.94 M | $3.51 M | 05/15/2020 | Q1 2020 | -$0.63 | $3.73 M | 03/30/2020 | Q4 2019 | -$1.07 | $4.17 M | $4.86 M | 12/18/2019 | Q3 2019 | -$0.44 | $3.94 M | $3.97 M | 06/29/2019 | Q2 2019 | -$0.81 | $3.30 M |
---|
A. TELA Bio, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 7th, 2024 based off last year's report dates.
A. In the previous quarter, TELA Bio, Inc. (NASDAQ:TELA) reported $-0.23 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.48 by $0.25.
A. The conference call for TELA Bio, Inc.'s latest earnings report can be listened to online.
A. The conference call transcript for TELA Bio, Inc.'s latest earnings report can be read online.
A. TELA Bio, Inc. (NASDAQ:TELA) has a recorded annual revenue of $58.45 M.
A. TELA Bio, Inc. (NASDAQ:TELA) has a recorded net income of $58.45 M. TELA Bio, Inc. has generated $-2.04 earnings per share over the last four quarters.
A. TELA Bio, Inc. (NASDAQ:TELA) has a price-to-earnings ratio of -2.65 and price/earnings-to-growth ratio is -0.07.